| Fluzone High-Dose Quadrivalent (influenza vaccine) / Evotec, Sanofi |
2021-003953-43: COVID-19: A Phase 3 Study to Evaluate Safety, Reactogenicity, and Immunogenicity of Co-administration of Ad26.COV2.S and Influenza Vaccines in Healthy Adults 18 Years of Age and Older |
|
|
| Ongoing | 3 | 1680 | Europe | Ad26.COV2.S, Afluria Quadrivalent, Fluzone High-Dose Quadrivalent, VAC31518, Suspension for injection, Suspension for injection in pre-filled syringe, Afluria Quadrivalent, Fluzone High-Dose Quadrivalent | Janssen Vaccines & Prevention B.V., Janssen Vaccines & Prevention B.V., Biomedical Advanced Research and Development Authority (BARDA) | Healthy Volunteers (Prevention of COVID-19 and influenza), Healthy Volunteers (Prevention of COVID-19 and influenza), Diseases [C] - Virus Diseases [C02] | | | | |
2019-001401-25: Study to Evaluate the Effectiveness of a High-Dose Quadrivalent Influenza Vaccine (QIV-HD) Compared to a Standard-Dose Quadrivalent Influenza Vaccine (QIV-SD) in Adults 65 Years of Age and Older |
|
|
| Not yet recruiting | 3 | 121000 | Europe | quadrivalent influenza vaccine high dose, VaxigripTetra, J07BB, Suspension for injection in pre-filled syringe, Efluelda, VaxigripTetra | Sanofi Pasteur Inc., Sanofi Pasteur | Prevention of influenza infection in adults from 65 years of age and older, Active immunisation of adults from 65 years of age and older againstinfluenza infection, Diseases [C] - Virus Diseases [C02] | | | | |
NCT04143451: Intradermal Influenza Vaccine With Topical Imiquimod in Elderly and Chronic Illness Patients |
|
|
| Recruiting | 3 | 4000 | RoW | Vaxigrip tetra, Fluzone high-dose, Aldara 5% Topical Cream, Aqueous cream BP | The University of Hong Kong | Influenza | 09/22 | 03/23 | | |
NCT06060457: A Study to Evaluate the Safety and Immune Response of mRNA-1345, a Vaccine Targeting Respiratory Syncytial Virus (RSV), When Co-administered With a Fluzone HD, in Adults ≥65 Years of Age |
|
|
| Completed | 3 | 1900 | US | Placebo, mRNA-1345, Fluzone HD | ModernaTX, Inc. | Respiratory Syncytial Virus | 06/24 | 06/24 | | |
2019-001974-27: Reducing the Burden of Influenza after Solid-Organ Transplantation: the STOP-FLU trial Reducción de la carga de enfermedad por gripe tras un trasplante de órganos sólidos: ensayo clínico STOP-FLU |
|
|
| Not yet recruiting | 2/3 | 780 | Europe | Suspension for injection in pre-filled syringe, Solution for injection in pre-filled syringe, VaxigripTetra®, Fluad®, Fluzone High Dose® | Centre Hospitalier Universitaire Vaudois (CHUV), Swiss National Science Foundation | Influenza in solid organ transplant patients Gripe en pacientes con trasplante de órgano sólido, Influenza in solid organ transplant patients Gripe en pacientes con trasplante de órgano sólido, Diseases [C] - Virus Diseases [C02] | | | | |
